Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Akebia Therapeutics
Akebia Therapeutics
(AKBA)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Fexeric
Ferric pyrophosphate citrate
2015-09-23
—
Vafseo
Vadadustat
2023-04-24
Chronic renal insufficiency
,
Anemia
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Vadadustat
healthy volunteers/patients
,
drug interactions
,
liver diseases
,
hepatic insufficiency
,
pharmacokinetics
,
chronic kidney failure
,
anemia
,
chronic renal insufficiency
,
kidney diseases
,
renal insufficiency
PRALICIGUAT
healthy volunteers/patients
,
type 2 diabetes mellitus
,
hypertension
,
diabetes mellitus
,
heart failure
,
diabetic nephropathies
,
kidney diseases
,
albuminuria
,
chronic renal insufficiency
,
proteinuria
,
focal segmental glomerulosclerosis
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use